Bottom line
Is MEDAX a good fund? The bottom line
MEDAX is a share class of MFS Emerging Markets Debt Fund, a managed emerging-markets bond mutual fund from MFS.
It charges 1.07% — about $107 a year on every $10,000 invested, more expensive than 63% of emerging-markets bond funds we track.
It returned +2.3% over one year, +0.1% a year over five years, +2.5% a year over ten (as of Dec 31, 2024, per its prospectus).
With $7.5 billion in net assets and 504 holdings, its largest position is MFS Institutional Money Market Portfolio (4.4%) and the top 10 make up 12.6% of the portfolio.
This share class carries a front-end sales charge of up to 4.25%; a no-load class or ETF alternative can avoid it.
What stands out
- Broadly diversified (504 holdings)
What to watch
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 4.25%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MEDAX invests in
The funds investment objective is to seek total return with an emphasis on high current income, but also considering capital appreciation.
MFS (Massachusetts Financial Services Company, the fund's investment adviser) normally invests at least 80% of the funds net assets in debt instruments of issuers that are tied economically to emerging market countries. Emerging markets are countries determined to have emerging market economies based on factors that demonstrate the country's financial and capital markets are in the development phase, including whether a particular country has a low- to middle-income economy according to the International Bank for Reconstruction and Development (the World Bank), the countrys designation by the International Monetary Fund as an emerging market, or the country's inclusion in an emerging market index. Emerging market countries include countries located in Latin America, Asia, Africa, the Middle East, and developing countries of Europe, primarily Eastern Europe. Debt instruments include…
From the fund's prospectus (filed Nov 26, 2025).
MEDAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MEDAX | +2.3% | +0.1% | +2.5% |
| Emerging-Markets Bond median | +14.5% | +1.6% | +4.0% |
Source: Fund prospectus, as of Dec 31, 2024
What MEDAX costs
On a $10,000 investment, MEDAX's 1.07% expense ratio costs about $107 a year. The prospectus estimates $1,685 in total costs over 10 years (assuming 5% annual returns). The median emerging-markets bond fund charges 0.92%.
MEDAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | MFS Institutional Money Market Portfolio | 4.42% |
| 2 | Argentina Republic Government International Bonds | 1.35% |
| 3 | Argentina Republic Government International Bonds | 1.08% |
| 4 | Ecuador Government International Bonds | 0.96% |
| 5 | Argentina Republic Government International Bonds | 0.95% |
| 6 | Dominican Republic | 0.89% |
| 7 | Colombia Government International Bonds | 0.82% |
| 8 | Dominican Republic | 0.73% |
| 9 | Paraguay Government International Bonds | 0.70% |
| 10 | Ecuador Government International Bonds | 0.69% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 12.6% of the fund. See all top 25 holdings and asset mix →